Karyopharm Therapeutics
KPTI
KPTI
134 hedge funds and large institutions have $334M invested in Karyopharm Therapeutics in 2021 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 58 increasing their positions, 34 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
45% less capital invested
Capital invested by funds: $608M → $334M (-$273M)
58% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 33
72% less call options, than puts
Call options by funds: $2.28M | Put options by funds: $8.13M
Holders
134
Holding in Top 10
1
Calls
$2.28M
Puts
$8.13M
Top Buyers
| 1 | +$12.8M | |
| 2 | +$2.78M | |
| 3 | +$1.83M | |
| 4 |
Two Sigma Investments
New York
|
+$1.46M |
| 5 |
Morgan Stanley
New York
|
+$1.46M |
Top Sellers
| 1 | -$8.28M | |
| 2 | -$7.55M | |
| 3 | -$6.15M | |
| 4 |
JGC
J. Goldman & Co
New York
|
-$5.51M |
| 5 |
AAM
AMI Asset Management
Los Angeles,
California
|
-$5.31M |